154 related articles for article (PubMed ID: 29895130)
21. DNA repair gene XRCC3 Thr241Met polymorphism and hepatocellular carcinoma risk.
Duan C; Zhang W; Lu J; Wu H; Liu M; Zhu W
Tumour Biol; 2013 Oct; 34(5):2827-34. PubMed ID: 23824570
[TBL] [Abstract][Full Text] [Related]
22. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
23. Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.
Chen TP; Lee HL; Huang YH; Hsieh MJ; Chiang WL; Kuo WH; Chou MC; Yang SF; Yeh CB
Tumour Biol; 2016 Feb; 37(2):2067-74. PubMed ID: 26341495
[TBL] [Abstract][Full Text] [Related]
24. DNA repair gene XRCC3 variants are associated with susceptibility to glioma in a Chinese population.
Huang JY; Yang JF; Qu Q; Qu J; Liu F; Liu FE; Xiong T; Lu SH
Genet Mol Res; 2015 Sep; 14(3):10569-75. PubMed ID: 26400288
[TBL] [Abstract][Full Text] [Related]
25. Haplotype Based Analysis of XRCC3 Gene Polymorphisms in Thyroid Cancer.
Sarwar R; Mahjabeen I; Bashir K; Saeed S; Kayani MA
Cell Physiol Biochem; 2017; 42(1):22-33. PubMed ID: 28490032
[TBL] [Abstract][Full Text] [Related]
26. Significance of genetic variants in DLC1 and their association with hepatocellular carcinoma.
Xie CR; Sun HG; Sun Y; Zhao WX; Zhang S; Wang XM; Yin ZY
Mol Med Rep; 2015 Sep; 12(3):4203-4209. PubMed ID: 26095787
[TBL] [Abstract][Full Text] [Related]
27. Recipient C6 rs9200 genotype is associated with hepatocellular carcinoma recurrence after orthotopic liver transplantation in a Han Chinese population.
Wang Z; Liao J; Wu S; Li C; Fan J; Peng Z
Cancer Gene Ther; 2016 Jun; 23(6):157-61. PubMed ID: 27173880
[TBL] [Abstract][Full Text] [Related]
28. The role of ERCC1 and AFP gene polymorphism in hepatocellular carcinoma.
Huang YL; Wu JR; Fang M; Zhao HL; Liu ZM; Ye J; Huang LS; Zhu B
Medicine (Baltimore); 2019 Apr; 98(14):e15090. PubMed ID: 30946366
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
Kim SS; Cho HJ; Lee HY; Park JH; Noh CK; Shin SJ; Lee KM; Yoo BM; Lee KJ; Cho SW; Cheong JY
Clin Biochem; 2016 Jul; 49(10-11):792-801. PubMed ID: 26968103
[TBL] [Abstract][Full Text] [Related]
30. A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma.
Zhao B; Lu J; Yin J; Liu H; Guo X; Yang Y; Ge N; Zhu Y; Zhang H; Xing J
Liver Int; 2012 Oct; 32(9):1451-9. PubMed ID: 22809120
[TBL] [Abstract][Full Text] [Related]
31. Haplotype-based case-control study of DNA repair gene XRCC3 and hepatocellular carcinoma risk in a Chinese population.
Luo HC; Zhang HB; Xin XJ; Huang WX
Tumour Biol; 2014 Apr; 35(4):3415-9. PubMed ID: 24307625
[TBL] [Abstract][Full Text] [Related]
32. miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patients.
Yu G; Xiao Q; Ma XP; Chen X; Shi Z; Zhang LY; Chen H; Zhang P; Ding DL; Huang HX; Saiyin H; Chen TY; Lu PX; Wang NJ; Yu H; Sun J; Conran C; Zheng SL; Xu J; Yu L; Jiang DK
Tumour Biol; 2016 Jul; 37(7):8961-72. PubMed ID: 26753964
[TBL] [Abstract][Full Text] [Related]
33. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
34. Secreted protein acidic and rich in cysteine gene variants: Impact on susceptibility and survival of hepatocellular carcinoma patients.
Darweesh SK; Abd Alziz RA; Omar H; Sabry D; Fathy W
J Gastroenterol Hepatol; 2019 Aug; 34(8):1424-1431. PubMed ID: 30422339
[TBL] [Abstract][Full Text] [Related]
35. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
Cai L; Cai X
Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
[TBL] [Abstract][Full Text] [Related]
36. Significant association between XRCC3 C241T polymorphism and increased risk of hepatocellular carcinoma: a meta-analysis.
Wu D; Jiang H; Yu H; Xu D; Liang J; Jin J
Tumour Biol; 2013 Dec; 34(6):3865-9. PubMed ID: 23873110
[TBL] [Abstract][Full Text] [Related]
37. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
38. Association between EGFR polymorphisms and the risk of lung cancer.
Liu C; Xu X; Zhou Y
Int J Clin Exp Pathol; 2015; 8(11):15245-9. PubMed ID: 26823874
[TBL] [Abstract][Full Text] [Related]
39. Contribution of DNA Double-strand Break Repair Gene XRCC3 Genotypes to Triple-negative Breast Cancer Risk.
Su CH; Chang WS; Hu PS; Hsiao CL; Ji HX; Liao CH; Yueh TC; Chuang CL; Tsai CW; Hsu CM; Lane HY; Bau DT
Cancer Genomics Proteomics; 2015; 12(6):359-67. PubMed ID: 26543082
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
